Affiliation:
1. Donetsk Center for Primary Medical Sanitary Care no. 9
Abstract
This review analyzes 33 publications on the effectiveness of inhaled antibiotics in patients with cystic fibrosis and evaluates their effect on bacterial resistance.
Publisher
LLC "Medical Knowledge and Technologies"
Reference33 articles.
1. Klinicheskiye rekomendatsii po vedeniyu patsiyentov s kistoznym fibrozom (mukovistsidozom). [Guidelines on management of cystic fibrosis patients]. Moscow, 2021. Available: https://cr.minzdrav.gov.ru/recomend/372_2 Accessed December 10, 2023.
2. Kuzovlev A.N., Moroz V.V., Golubev A.M., Polovnikov S.G. Inhaled antibiotics in the treatment of nosocomial pneumonia. Obschaya Reanimatologiya, 2013, vol. 9, no. 6, pp. 61-70. (In Russ.) https://doi.org/10.15360/1813-9779-2013-6-61
3. Chukina M.A., Lukina M.V., Andruschishina T.B. et al. Inhaled amikacin in patients with nosocomial pneumonia in the intensive care unit. Vestnik Smolenskoy Gosudarstvennoy Meditsinskoy Akademii, 2019, vol. 18, no. 1, pp. 137-144. (In Russ.)
4. Bassetti M., Luyt C.E., Nicolau D.P., Pugin J. Characteristics of an ideal nebulized antibiotic for the treatment of pneumonia in the intubated patient. Ann. Intensive Care, 2016, vol. 6, no. 1, pp. 35. https://doi.org/10.1186/s13613-016-0140-x PMID: 27090532
5. Choi J., Novak K., Thompson R. Evaluation of inhaled tobramycin in early eradication of Pseudomonas aeruginosa in infants with cystic fibrosis. J. Pediatr. Pharmacol. Ther., 2020, vol. 25, no. 8, pp. 709-716. https://doi.org/10.5863/1551-6776-25.8.709 PMID: 33214782